![](/img/cover-not-exists.png)
Prospective Comparison of Sorafenib and Sunitinib for Second-Line Treatment of Cytokine-Refractory Kidney Cancer Patients
Herrmann, Edwin, Bierer, Stefan, Gerss, Joachim, Kö, pke, Thomas, Hertle, Lothar, Wü, lfing, ChristianVolume:
74
Year:
2008
Language:
english
Journal:
Oncology
DOI:
10.1159/000151369
File:
PDF, 175 KB
english, 2008